| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000030880 |
| Receipt No. | R000035249 |
| Official scientific title of the study | Examination of 1 week continuous ingestion of drink containing plant extract. A-18001 |
| Date of disclosure of the study information | 2018/01/22 |
| Last modified on | 2018/07/19 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Examination of 1 week continuous ingestion of drink containing plant extract. A-18001 | |
| Title of the study (Brief title) | Examination of 1 week continuous ingestion of drink containing plant extract. A-18001 | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adults | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To examine the effects of plant extract on vascular function. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Skin temperature before and after 1day drink ingestion. |
| Key secondary outcomes | Peripheral blood flow and subjective evaluation. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | YES |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Drink containing plant extract (1 week continuous ingestion)->washout period->placebo drink not containing plant extract (1 week continuous ingestion) | |
| Interventions/Control_2 | Placebo drink not containing plant extract (1 week continuous ingestion)->washout period->Drink containing plant extract (1 week continuous ingestion) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1.Healthy adults
2.Person whose estradiol cycle is stable between 28 and 32 days. 3.Person who is sensitive to cold. 4.Person who agrees not to ingest specified foods and supplements during the test period. |
|||
| Key exclusion criteria | 1.Person whose body math indexes are less than 18.5 or more than 25.0.
2.Person whose diastolic blood pressures are more than 90mmHg and systolic ones are more than 140mmHg. 3.Person who has severe allergic disease as rhinitis, atopicdermatitis. 4.Person who is pregnant, lactating or planned to become pregnant during the test period. 5.Patient with vascular function disorder. 6.Person who has problems with electrocardiogram test such as arrhythmia. 7.Person who takes medicine. 8.Person who regularly goes to hospital or went to the medical institution within a month. 9.Current smoker. 10.Person who plans to participate in the other clinical studies. 11.Person who is judged as unsuitable for the study by the investigator for other reasons. |
|||
| Target sample size | 24 | |||
| Research contact person | |
| Name of lead principal investigator | Akane Suma |
| Organization | Kao Corporation |
| Division name | R&D-Skin Care Products Research |
| Address | 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan |
| TEL | +81-3-5630-9581 |
| suma.akane@kao.com | |
| Public contact | |
| Name of contact person | Norio Shimizu |
| Organization | Kao Corporation |
| Division name | R&D-Skin Care Products Research |
| Address | 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan |
| TEL | +81-465-35-3175 |
| Homepage URL | |
| shimizu.norio@kao.com | |
| Sponsor | |
| Institute | Kao Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | SOUKEN Co., Ltd. |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 花王株式会社(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035249 |